EPHA2 and cancer: The expression of EphA2 is not significantly correlated with common immune checkpoints such as PDCD1, CTLA4, and CD274, but it can enhance the infiltration of neutrophils, bone marrow dendritic cells, and macrophages, suggesting that EphA2 can regulate cancer development by affecting immune cell infiltration through LLPS (128).